-transparent.png){kind=logo}
Effects of chlorpromazine (CPZ) on plasma GH and prolactin levels were observed in conscious rats provided with chronic indwelling right atrial cannulae. The administration of CPZ (200 micrograms/100 g b.w. iv) suppressed episodic plasma GH burst and resulted in significant elevations of plasma prolactin levels. These were also observed in rats in which two types of hypothalamic deafferentation, i.e. anterior and complete, had been carried out. The data suggest that CPZ acts within the medial basal hypothalamus and inhibits episodic plasma GH secretion. In addition, it is inferred that catecholamines are involved in the generation of episodic plasma GH burst.
Related Publications
I Wakabayashi, and
M Kanda, and
N Miki, and
R Demura, and
K Shizume
January 1978,
Endocrinology,
I Wakabayashi, and
M Kanda, and
N Miki, and
R Demura, and
K Shizume
January 1993,
The Journal of pediatric endocrinology,
I Wakabayashi, and
M Kanda, and
N Miki, and
R Demura, and
K Shizume
August 1979,
Endocrinology,
I Wakabayashi, and
M Kanda, and
N Miki, and
R Demura, and
K Shizume
January 1982,
Neuroendocrinology,
I Wakabayashi, and
M Kanda, and
N Miki, and
R Demura, and
K Shizume
March 1995,
Endocrinology,
I Wakabayashi, and
M Kanda, and
N Miki, and
R Demura, and
K Shizume
January 1990,
Acta paediatrica Scandinavica. Supplement,
I Wakabayashi, and
M Kanda, and
N Miki, and
R Demura, and
K Shizume
September 1990,
Metabolism: clinical and experimental,
I Wakabayashi, and
M Kanda, and
N Miki, and
R Demura, and
K Shizume
January 2002,
International journal of toxicology,
I Wakabayashi, and
M Kanda, and
N Miki, and
R Demura, and
K Shizume
January 1982,
The Journal of clinical investigation,
I Wakabayashi, and
M Kanda, and
N Miki, and
R Demura, and
K Shizume
July 2000,
Comparative biochemistry and physiology. Toxicology & pharmacology : CBP,
